None listed
Conditions
Brief summary
Patients undergoing elective short duration surgery (<1-2 h) will be participated in this study. All devices will inserted into each patient in random order. Patients will be premedicated with 7.5 mg oral midazolam 15 min prior to surgery. Standard monitoring will be applied (ECG, BP, SpO2) and the anaesthesia will conducted according to local standards. Neuromuscular blocker will not administered. All supraglotic airway devices (c-LMA, proseal LMA and i-gel) will inserted in a standardised manner according to the manufacturers' instructions. Insertion time, first-time insertion success rate, oropharyngeal leak and peak pressure, leak fraction and complications will be recorded.
Interventions
All supraglottic airway devices (SGAD) were inserted by 5 years experienced anesthesist.
Group C: c-LMA inserted
Group P: Proseal LMA inserted
Group I: i-gel inserted
c-LMA with an inflatable cuff; is an airway device that provides an easier and more reliable airway than the facial mask, while protecting it from the disadvantages of endotracheal intubation.
p-LMA is an airway device developed by modifying c-LMA. The application of high-pressure positive ventilation is one of the advantages tha
All supraglottic airway devices (SGAD) were inserted by 5 years experienced anesthesist. Group C: c-LMA inserted Group P: Proseal LMA inserted Group I: i-gel inserted c-LMA with an inflatable cuff; is an airway device that provides an easier and more reliable airway than the facial mask, while protecting it from the disadvantages of endotracheal intubation. p-LMA is an airway device developed by modifying c-LMA. The application of high-pressure positive ventilation is one of the advantages that the drain tube near the ventilation tube can be emptied stomach. i-gel thermoplastic elastomer structure, it flexes at body temperature and fully conforms to the supraglottic texture, thus minimizing air leakage.It has the drain tube near the ventilation tube. Insertion time, first-time insertion success rate, oropharyngeal leak and peak pressure, leak fraction and complications were recorded.
Sponsors
Reyhan Polat
Study design
Allocation
Randomised controlled trial
Primary purpose
Prevention
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Healthy volunteers
No
Inclusion criteria
ASA I-II who were scheduled to undergo hernioraphy or urologic surgery
Exclusion criteria
Patients with respiratory tract disease, known airway problems or any condition that increases the risk of gastro-oesophageal regurgitation were excluded.
Outcome results
None listed